Tagged with OP

The Pharmacy in 2019
“Restricting Drug Patent Settlements is Bad for US Patients”
Perspectives from J.P. Morgan’s 2019 Health Care Investor Conference
Top 10 Drugs in Canada 2017
The Ideal Pharma Country Manager: South Korea (Egon Zehnder)
Damaso Molero – General Manager, 3P Biopharmaceuticals, Spain
Daniel-Anibal Garcia Diego – President, FEDHEMO, Spain
Eduardo Barriga – General Manager, Boiron Spain
Real-World Evidence – A Game Changer for Pharma
China Set to Become OxyContin’s Second Largest Market
Dan Zhang – Executive Chairman, Fountain Medical Development (FMD), China
Top 10 Korean Pharma Companies
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here